Antiphospholipid antibodies in convalescent plasma of donors recovered from mild COVID-19 infection.
Dorit BlicksteinMarina IzakTalia Filipovich-RimonOsnat Garach-JehoshuaNaomi Rahimi-LeveneEilat ShinarRamzia Abu HamadAdina Bar-ChaimMaya Koren-MichowitzPublished in: Vox sanguinis (2023)
The low prevalence of APLA in CCP donors reassures the safety of CCP administration to patients with severe COVID-19.